Skip to main content
Premium Trial:

Request an Annual Quote

Billions for Antivirals

The US is investing billions of dollars into antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

The $3.2 billion in funding for the new Antiviral Program for Pandemics comes from the $1.9 trillion American Rescue Plan and could expedite ongoing studies, NBC News adds. The hope, the Journal says, is to develop a Tamiflu-like pill people can take at any initial signs of COVID-19.

"New antivirals that prevent serious COVID-19 illness and death, especially oral drugs that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives," Anthony Fauci, chief White House medical advisor and director of the National Institute of Allergy and Infectious Diseases, says according to the Journal, adding that vaccines "remain the centerpiece of our arsenal" fighting the pandemic.

In particular, the program includes $300 million for lab and research support, nearly $1 billion for preclinical and clinical evaluation, about $700 million for development and manufacturing, and $1.2 billion to form collaborative drug discovery groups called Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern to spur antiviral drug discovery and development.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.